Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher Scientific raises outlook as Thermo Fisher Scientific stock hits a 52-week high

Published on 10/06/2026 at 17:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 10.00 percent to USD 11.99 billion in the second quarter. For Thermo Fisher Scientific stock, 2026 earnings outlook is USD 24.93-25.33.

Schwarzweißfoto eines Technikers an einem großen Bioreaktortank in einer Fertigungshalle — Schwarzweiße Reportage-Aufnahme für Thermo Fisher Sci. US8835561023 dokumentiert Techniker an industrieller Bioreaktor-Anlage im Werk, Illustration mit AI erstellt.

Thermo Fisher Scientific stock reached a reported 52-week high on October 6, 2026, while the companys raised 2026 outlook remained the central earnings signal. Investing.com reported the market event, and MarketBeat documented the companys updated full-year outlook.

Revenue beats expectations

In the second quarter of 2026, Thermo Fisher generated USD 11.99 billion in revenue, up 10.00 percent from the prior-year period. The figure exceeded the USD 11.71 billion analyst consensus cited by MarketBeat in its September 30, 2026 report.

Adjusted earnings per share reached USD 6.03 in the second quarter, versus consensus of USD 5.71 and the prior-year figure of USD 4.28. That combination gives investors two separate reference points: a USD 0.32 consensus beat and a USD 1.75 year-over-year increase in adjusted earnings per share.

Outlook sets the next test

Management set full-year 2026 adjusted earnings guidance at USD 24.93-25.33 per share, according to MarketBeat on September 30, 2026. The same report cited expected full-year earnings of USD 25.13 per share from analysts, placing the midpoint of the company range at USD 25.13.

The next scheduled reporting date is October 28, 2026, for the third quarter, as listed by TradingView. That date gives the market a defined checkpoint for testing whether second-quarter revenue growth and the raised earnings outlook are carrying into the second half.

Stock stays below its yearly high

On the NYSE, Thermo Fisher Scientific was trading at USD 658.52 on October 6, 2026 at 11:05 a.m. EDT, down 2.69 percent from the USD 676.76 prior close. Its market capitalization was USD 243.5 billion, while the USD 435.27 to USD 694.33 52-week range places the latest quote 5.16 percent below the yearly high.